🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free
    Conexus Financial Partners, L.P. logo

    Conexus Financial Partners, L.P.

    VC · Bridgewater (United States)

    VC
    Series A
    Series B
    Cloud/SaaS

    Sign up free to access full profile and submit your pitch.

    About

    Conexus Financial Partners, L.P. is a venture capital firm specializing in investments in medical technologies and, to a lesser extent, in eHealth and healthcare services. Within medical technologies, the firm focuses on medical devices, biomaterials, drug delivery, bioinformatics, enabling technologies, and protienomics. It seeks to invest in companies that have matured beyond laboratory research, have competitive advantage in proprietary technology, first mover advantage, or favorable distribution channel, and have developed technologies and services that can significantly impact clinical practice and the underlying economics of healthcare delivery. The firm prefers to invest in Mid-Atlantic States of Delaware, Maryland, New Jersey, Pennsylvania, and Virginia as well as in the Northeastern States of Connecticut, Massachusetts, and New York. However it will also consider investments beyond this geographic area. The firm invests between $500,000 to $4 million, typically between $1 million to $2 million per investment round. It typically invests in the first or second round of institutional funding, providing an initial round of $500,000 to $2 million and a second round of up to an additional $2 million. The firm structures its investments as convertible preferred stock or notes with warrants. It prefers to be a lead investor but also syndicates with other venture capital firms. Conexus Financial Partners, L.P. was founded in 2000 and is based in Bridgewater, New Jersey.

    Visit website ↗

    Investment Criteria

    Sign up free to see full investment criteria and submit your pitch.

    Min. Ticket Size
    $500,000
    Max. Ticket Size
    $2,000,000
    Investment Stage
    Series A
    Series B
    Focus Areas

    Similar Investors

    We use cookies to enhance your experience. Read our Privacy Policy